Literature DB >> 22886969

Contribution of IL-17 to mouse hepatitis virus strain 3-induced acute liver failure.

Lin Zhu1, Tao Chen1, Yulei Lu1, Di Wu1, Xiaoping Luo2, Qin Ning3.   

Abstract

Recently, the Th17 cells and IL-17 have been shown to play a critical role in the immune-mediated liver injury in hepatitis B, while their functions in acute liver failure have not been well elucidated yet. In this study, we primarily investigated the role of IL-17 in the development of mouse hepatitis virus strain 3 (MHV-3)-induced acute liver failure. IL-17 mRNA levels in liver tissue were quantified by using quantitative real-time polymerase chain reaction, and cytokine IL-17 levels in liver tissue and serum were determined by using ELISA in MHV-3-induced murine fulminant hepatitis model. The IL-17 expression levels on CD4(+)T and CD8(+)T cells were determined by using flow cytometry. The correlation between IL-17 level and liver injury was studied. Th17 associated cytokines were also investigated by intracellular staining. Our results showed that the IL-17 expression was significantly elevated in the liver and serum of BALB/cJ mice infected with MHV-3. Moreover, a time course study showed that the percentage of both IL-17-producing CD4(+)T cells and IL-17-producing CD8(+)T cells was increased remarkably in the liver starting from 48 h and peaked at 72 h post-infection. There was a close correlation between hepatic or serum IL-17 concentration and the severity of liver injury defined by ALT level, respectively. Th17 associated cytokines, IL-6, IL-21 and IL-22, were also increased significantly at 72 h post-infection. It was concluded that IL-17 may contribute to the pathogenesis of MHV-3-induced acute liver failure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886969     DOI: 10.1007/s11596-012-0095-6

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  26 in total

1.  A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus.

Authors:  Ye Zhang; Melissa A Cobleigh; Jian-Qi Lian; Chang-Xing Huang; Carmen J Booth; Xue-Fan Bai; Michael D Robek
Journal:  Gastroenterology       Date:  2011-06-25       Impact factor: 22.682

2.  Involvement of Th17 and Th1 effector responses in patients with Hepatitis B.

Authors:  Yufu Ye; Xiaojun Xie; Jiwei Yu; Lin Zhou; Haiyang Xie; Guoping Jiang; Xiaobo Yu; Wenjin Zhang; Jian Wu; Shusen Zheng
Journal:  J Clin Immunol       Date:  2010-07       Impact factor: 8.317

Review 3.  IL-17 in protective immunity to intracellular pathogens.

Authors:  Shabaana A Khader; Radha Gopal
Journal:  Virulence       Date:  2010 Sep-Oct       Impact factor: 5.882

4.  The interleukin-17 pathway is involved in human alcoholic liver disease.

Authors:  Arnaud Lemmers; Christophe Moreno; Thierry Gustot; Raphaël Maréchal; Delphine Degré; Pieter Demetter; Patricia de Nadai; Albert Geerts; Eric Quertinmont; Vincent Vercruysse; Olivier Le Moine; Jacques Devière
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

5.  The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.

Authors:  Philip A Marsden; Qin Ning; Laisum S Fung; Xioping Luo; Yue Chen; Michael Mendicino; Anand Ghanekar; Jeremy A Scott; Teresa Miller; Camie W Y Chan; Mathew W C Chan; Wei He; Reginald M Gorczynski; David R Grant; David A Clark; M James Phillips; Gary A Levy
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

6.  Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.

Authors:  Ji-Yuan Zhang; Zheng Zhang; Fang Lin; Zheng-Sheng Zou; Ruo-Nan Xu; Lei Jin; Jun-Liang Fu; Feng Shi; Ming Shi; Hui-Fen Wang; Fu-Sheng Wang
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

7.  Implication of Th17 and Th1 cells in patients with chronic active hepatitis B.

Authors:  Jian Ge; Kai Wang; Qing-Hua Meng; Zhao-Xia Qi; Fan-Li Meng; Yu-Chen Fan
Journal:  J Clin Immunol       Date:  2009-09-10       Impact factor: 8.317

8.  Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells.

Authors:  Takako Nagata; Laura McKinley; Jacques J Peschon; John F Alcorn; Shean J Aujla; Jay K Kolls
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

9.  Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression.

Authors:  Li Zhao; Yanli Tang; Zhengrui You; Qixia Wang; Shuwen Liang; Xiaofeng Han; Dekai Qiu; Jue Wei; Yuan Liu; Lei Shen; Xiaoyu Chen; Yanshen Peng; Zhiping Li; Xiong Ma
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

10.  Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation.

Authors:  Lauren A Zenewicz; George D Yancopoulos; David M Valenzuela; Andrew J Murphy; Margaret Karow; Richard A Flavell
Journal:  Immunity       Date:  2007-10-04       Impact factor: 31.745

View more
  2 in total

1.  γδ T Cells Contribute to the Outcome of Murine Fulminant Viral Hepatitis via Effector Cytokines TNF-α and IFN-γ.

Authors:  Di Wu; Wei-Ming Yan; Hong-Wu Wang; Da Huang; Xiao-Ping Luo; Qin Ning
Journal:  Curr Med Sci       Date:  2018-08-20

2.  Identifying the Mechanism of Polygoni Cuspidati Rhizoma et Radix in Treating Acute Liver Failure Based on Network Pharmacology and Molecular Docking.

Authors:  Jing Hong; Jie Ding; Han-Han Hong; Xiao-Wan Xu; Bo Pan; Yi Ruan; Xiao-Feng Zhai
Journal:  Gastroenterol Res Pract       Date:  2022-04-08       Impact factor: 1.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.